The Dutch STRIDER (Sildenafil TheRapy In Dismal Prognosis Early-onset Fetal Growth Restriction)
Phase of Trial: Phase II/III
Latest Information Update: 03 Aug 2018
Price : $35 *
At a glance
- Drugs Sildenafil (Primary)
- Indications Fetal growth retardation
- Focus Therapeutic Use
- Acronyms STRIDER
- 31 Aug 2018 Biomarkers information updated
- 01 Aug 2018 The trial has been discontinued in Netherlands.
- 24 Jul 2018 Status changed from recruiting to discontinued.